CLOs on the Move

OnKure Therapeutics

www.onkuretherapeutics.com

 
OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure`s drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenvironment such that checkpoint inhibition is optimized.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Keith Olivia
General Counsel and Vice President of Corporate Affairs Profile
Rogan Nunn
General Counsel and Secretary Profile

Similar Companies

A Better Way

​A Better Way is a San Francisco Bay Area nonprofit that empowers children and families to develop the insights, life skills, and permanent relationships that promote their social, emotional, educational and economic well- being.

Your MedSource

Your MedSource is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cardiology Consultants of Philadelphia

As America’s largest independent cardiac care practice, CCP is home to the most experienced cardiologists in the Philadelphia region.

harris pharmaceutical

harris pharmaceutical is a Fort Myers, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrphoMed Inc

OrphoMed is a San Francisco based clinical stage pharmaceutical company focused on the development of novel first-in-class dimer conjugates with superior therapeutic profiles. The company is leveraging its proprietary dimer platform technology to address the issues of visceral hypersensitivity and hypermotility in functional gastrointestinal disorders. OrphoMed dimers are protected by composition of matter and method of use patents.